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Background:	 Short	 sprints	 have	been	 shown	 to	 reduce	exercise	 induced	hypoglycaemia	 in	
controlled	laboratory	settings.	This	study	tested	the	hypothesis	that	incorporating	sprinting	
into	 moderate	 intensity	 exercise	 can	 reduce	 the	 incidence	 of	 exercise	 mediated	
hypoglycaemia	in	individuals	with	T1D	in	a	free-living	setting.		
Methods:	 Individuals	 with	 T1D	 were	 recruited	 into	 a	 prospective	 randomised	 controlled	
cross	 over	 study.	 Participants	 completed	 three	 14-day	 periods	 in	 random	 order.	 In	 one	
period	participants	undertook	moderate	intensity	exercise	for	a	minimum	of	30	minutes,	at	
least	 3	 times	 a	week	 (control	 period).	 In	 the	 other	 periods,	 participants	 incorporated	 10s	
(every	20	mins)	or	4s	sprints	(every	2	mins)	into	the	exercise	regimen.	The	primary	outcome	
was	the	incidence	of	hypoglycaemia,	defined	as	sensor	glucose	readings	<3.5mmol/L	for	≥	20	
minutes	 over	 the	 14-day	 period.	 Secondary	 outcome	measures	 included	 the	 incidence	 of	
hypoglycaemia	<3.1mmol/L	and	percentage	time	<3.1mmol/L	and	<3.5mmol/L.		
Results:	24	 participants	 completed	 the	 study.	 There	 was	 no	 difference	 in	 hypoglycaemic	
events	 (<3.5mmol/L)	 between	 the	 4s	 and	 control	 period	 (p=0.28)	 or	 the	 10s	 and	 control	
period	 (p=0.05).	 The	 10s	 period	 was	 associated	 with	 fewer	 hypoglycaemia	 events	
<3.1mmol/L	 than	the	control	period	 (p=0.04),	with	an	 incidence	rate	of	0.40	 (95%	CI	0.26-
0.55),	0.33	(95%	CI	0.21-0.45)	and	0.28	(95%	CI	0.17-0.38)	events	per	day	in	control,	4s	and	
10s	 periods	 respectively.	 The	 10s	 period	 was	 associated	 with	 a	 reduction	 in	 time	 spent	
<3.5mmol/L	 (3.1%	 vs.	 2.1%,	 p=0.03)	 and	 time	 spent	 <3.1mmol/L	 (1.9%	 vs	 1.2%,	 p=	 0.03).	
There	was	no	increase	in	nocturnal	hypoglycaemia	during	the	sprinting	periods.		
Conclusion:	 In	 a	 free-living	 setting,	 the	 inclusion	 of	 10s	 sprints	 into	 moderate	 intensity	








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Visit 1: (Familiarisation Session)  
Familiarisation Week 
1 Week Washout 
2 Week Testing Period 
1-2 Week Washout 
2 Week Testing Period 
1-2 Week Washout 
2 Week Testing Period 
 Visit 2 
 Visit 3 
 Visit 4 
 Visit 5 
 Visit 6 
 Visit 7 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Hypoglycaemia	Outcomes	 Control	 4s	 p	 10s	 p	
Events:	SG<3.5mmol/L	for	≥20	mins,	
incidence	rate	per	24	hrs		
0.6	 0.6	 0.28	 0.5	 0.05	
Events:	SG<3.1mmol/L	for	≥20	mins/24	hrs	 0.4	 0.3	 0.27	 0.3*	 0.04a	
%	Time	(hours)	spent	SG	<3.5mmol/L	 3.1	 2.5	 0.18	 2.1*	 0.03b	
%	Time	(hours)	spent	SG	<3.1mmol/L	 1.9	 1.4	 0.13	 1.2*	 0.03b	
Night	events	(22:00-06:00):	SG<3.1mmol/L	
for	≥20	mins/24	hrs	
0.5	 0.4	 0.47	 0.2*	 0.04a	
%	Day	time	(06:00-22:00)	spent	SG	
<3.1mmol/L	
1.9	 1.2*	 0.01c	 1.1*	 0.01b	
%	Day	time	(06:00-22:00)	spent	SG	
<3.5mmol/L	
3.0	 2.1*	 0.02c	 2.0*	 0.01b	
%	Day	time	(06:00-22:00)	spent	SG	
<3.9mmol/L	


























































































































































































































13.3	 14.5	 0.81	 4.7*	 0.02	





































		 Control	 4s	 pa	 10	 pb	






































































	 	 	 	 	 	
	 Control	 4s	 pa	 10s	 pb	

















































































































































































































































































































































































































































































































































































































































































































Appendix	A:	Clarkes	Hypoglycaemia Awareness Questionnaire 
 
	 	
Clarke’s Hypoglycaemia Awareness Questionnaire _Clarke et al 1995 (modified 2013) 
 
Hypoglycaemia Awareness Questionnaire 
 
     Name: ___________________________________________         Date __________________ 
 






















          R1    
          R1 











1. Tick the box that best describes you? (tick only one) 
 
r I always have signs when my BGL is low  
r I sometimes have signs when my BGL is low 
r I never have signs when my BGL is low  
r I no longer have signs when my BGL is low 
 
 
2. Have you lost some of the signs and symptoms that used to occur 
when your BGL was low? 
 
r Yes        
r No          
 
 
3. In the past 6 months how many times have you had a hypo episode 
where you have been confused, disorientated or lethargic, and needed 
help to treat your hypo? 
 
r Never 
r One or twice 
r Every other month   
r Once a month   
r More than once a month 
 
 
4. In the past year how often have you had a severe hypo episode, where 
you were unconscious or had a seizure? 
 
r Never 
r 1 to 11 times 
r 12 times or more 
 
 
5. In the last month how many times have you had a blood glucose level 
(BGL) of less than 3.9 mmol, with symptoms? 
 
r Never  
r 1 to 3 times in the month 
r Once a week   
r 2 to 3 times a week   
r More than 3 times a week 





















































6. In the last month how many times have you had a blood glucose level 
(BGL) of less than 3.9 mmol, without any symptoms? 
 
r Never  
r 1 to 3 times in the month 
r Once a week   
r 2 to 3 times a week   
r More than 3 times a week 
r Almost every day   
 
 
7. How low does your BGL fall before you notice any signs? 
 
r Less than 2.2   
r 2.2 – 2.7   
r 2.8 – 3.3   










8. Can you tell your BGL is low by certain signs or behaviour? 
  
r Never  
r Rarely  
r Sometimes   
r Often  




























































PARTICIPANT INFORMATION SHEET  
 
 
The benefits of sprinting for improving blood glucose management in 
individuals with type 1 diabetes mellitus 
 
Why are we doing the study? 
The aim of this study is to find out whether adding short sprints to exercise in real-life 
improves blood glucose management in people with type 1 diabetes. To determine this we are 
asking people with diabetes to try adding 4 and 10 second sprints to their exercise. 
 
Who is carrying out the study? 
The Diabetes and Obesity Research Team at Princess Margaret Hospital (PMH) and the 
Telethon Kids Institute, together with the School of Sports Science, Exercise and Health at the 
University of Western Australia, will be running the study. 
 
What will the study tell us? 
The study will tell us whether adding short sprints to a period of exercise will help to 
minimise changes in blood glucose levels in people with type 1 diabetes. 
 
Do you have to take part? 
No. You do not have to take part in this study. If you decide to take part and then change your 
mind, you can stop at any time.  
 
What will you be asked to do if you decide to take part in this study? 
You will be asked to visit PMH 8 times. We will ask you to test three different types of 
activity in two week blocks. These are doing what you normally do (control), adding a 4 
second sprint to your exercise, or adding 10 second sprint to your exercise. 
 
Visit 1 –  
On your first visit, you will meet the study team and be able to ask any questions about the 
study. You will then be fitted with a Continuous Glucose Monitoring System (CGMS) to 
monitor your blood glucose levels. This device includes a small sensor that will be placed just 
under your skin using a small needle and an insertion tool. The sensor will send glucose 
readings to a monitor the size of an insulin pump that you will carry in your pocket or clipped 
to your belt. You will also be given an exercise activity watch to wear during exercise to 
monitor your physical activity levels. You will then spend the next week at home getting use 
to the equipment and practicing the sprints.   
 
Visit 2 -  
One week later, you will come back to PMH to return the CGMS, and exercise activity watch. 
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Visit 3 –  
Seven (7) days later you will visit the research unit again and we will re-fit a CGMS, and give 
you the exercise activity watch to wear during exercise. You will also be given instructions 
for adding a 4 second or 10 second sprint to your exercise or completing your normal routine. 
For the next 2 weeks, you will follow these instructions every time you exercise. You will 
also have to write down when and for how long you exercise, when you have a hypo and what 
you eat after exercise. During the study, you will change your glucose sensor at home after 7 
days.  
 
Visit 4 –  
After the two weeks is up, you will come back to PMH to return the CGMS, and exercise 
activity watch. You will then be sent home to continue your usual activity for one week 
without any monitoring. 
 
Visit 5 & 7–  
Are the same as visit 3, however you will try a different type of activity. 
 
Visit 6 & 8 –  
Are the same as visit 4. 
   
 
What do you need to do to be in the study? 
Please contact Tarini or Niru (contact details below), who will make an appointment for your 
first visit. To be part of the study you must be between 14 and 35 years old, physically active 
at least 3 times per week, with an HbA1c of less than 9%, and aware of your hypos. We will 
work out if you’re aware of your hypos by asking you to answer a questionnaire. You will 
have to wear a CGMS continuously during the study. During exercise you will need to wear 
an exercise watch and follow the instructions given to you. If you have an injury or any health 
conditions (other than type 1 diabetes), please let us know as you may not be able to 
participate in the study.  
 
Is there likely to be a benefit to me? 
Yes. You will benefit by learning about how to manage your blood glucose levels during 
exercise. You will also be given continuous glucose readings that can be used to help improve 
your blood glucose management, if necessary. 
 
Is there likely to be a benefit to other people in the future? 
Yes. The outcomes of this study will help to work out the benefit of including short sprints 
into periods of exercise for minimising changes in blood glucose levels in people with type 1 
diabetes. This will help to improve guidelines for people with type 1 diabetes to exercise 
without the worry of hypos. 
 
What are the possible risks and/or side effects? 
There is a risk of hypos when you exercise. But, this will be small since you will mostly do 
what you normally do and we will give you the most up-to-date recommendations for keeping 
this risk small.  
 
There is also a small risk of infection with the CGMS sensor. But, this risk is small and we 
will follow correct instructions to keep it that way. We have used these devices in lots of other 
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What are the possible discomforts and/or inconveniences? 
You may find that wearing the CGMS all the time is a bit of a bother, but most people tolerate 
this device very well. 
 
Where is my information kept? 
All information collected during the study will be kept in a secure office and on computer 
files that need a password at PMH. 
 
What about my privacy? 
Your identity will be kept private by using codes to label data sheets and blood samples.. 
 
Who has approved the study? 
The study has been approved by the Princess Margaret Hospital Human Research Ethics 
Committee. 
 
Who to contact for more information about this study: 
If you would like more information about this study, please do not hesitate to contact a 
member of the research team.  We are very happy to answer your questions. 
 
Dr Tarini Chetty, Fellow on 6229 3322 or Tarini.Chetty@health.wa.gov.au 
 
Ms Niru Paramalingam, Clinical Research Coordinator and Research Nurse on 9340 8671 or 
nirubasini.paramalingam@telethonkids.org.au 
 
Who to contact if you have any concerns about the organisation or running of the study? 
If you have any concerns or complaints regarding the conduct of this study, you can contact 
the Director of Medical Services at PMH (Telephone No:  (08) 9340 8222).  Your concerns 
will be reviewed by the Ethics Committee who is monitoring the study. 
 
What to do next if you would like to take part in this research: 
If you would like to take part in this study, please contact Dr. Chetty on 6229 3322 Niru 
Paramalingam on 9340 8671.  
 
 





































PLEASE NOTE THAT PARTICIPATION IN RESEARCH STUDIES IS VOLUNTARY 
AND SUBJECTS CAN WITHDRAW AT ANY TIME WITH NO IMPACT ON 
CURRENT OR FUTURE CARE. 
 
 
I ................................................................................................................................. have read 
       Given Names                                                  Surname 
 
the information explaining the study entitled  
 
The benefits of sprinting for improving blood glucose management in 
individuals with type 1 diabetes mellitus 
 
I have read and understood the information given to me.  Any questions I have asked have 
been answered to my satisfaction. 
 
 









Dated ................................. day of ............................................................ 20 .......... 
 
 






I, ........................................................................... have explained the above to the  
  (Investigator’s full name) 
 









I	enjoyed	it	 1	 2	 3	 4	 5	 6	 7	 I	hated	it	
I	felt	bored	 1	 2	 3	 4	 5	 6	 7	 I	felt	interested	
I	disliked	it	 1	 2	 3	 4	 5	 6	 7	 I	liked	it	
It	was	pleasurable	 1	 2	 3	 4	 5	 6	 7	 It	was	not	pleasurable	
It	was	no	fun	at	all	 1	 2	 3	 4	 5	 6	 7	 It	was	lots	of	fun	
It	gave	me	energy	 1	 2	 3	 4	 5	 6	 7	 It	was	tiring	
It	made	me	depressed	 1	 2	 3	 4	 5	 6	 7	 It	made	me	happy	
It	was	very	unpleasant	 1	 2	 3	 4	 5	 6	 7	 It	was	very	pleasant	
My	body	felt	good	 1	 2	 3	 4	 5	 6	 7	 My	body	felt	bad	
I	got	something	out	of	
it	
1	 2	 3	 4	 5	 6	 7	 I	got	nothing	out	of	it	
It	was	very	exciting	 1	 2	 3	 4	 5	 6	 7	 It	was	not	at	all	exciting	
It	frustrated	me	 1	 2	 3	 4	 5	 6	 7	 It	didn’t	frustrate	me	
It	was	not	at	all	
interesting	
1	 2	 3	 4	 5	 6	 7	 It	was	very	interesting	
It	gave	me	strong	
feelings	of	success	
1	 2	 3	 4	 5	 6	 7	 It	didn’t	give	me	feelings	
of	success	
It	felt	good	 1	 2	 3	 4	 5	 6	 7	 It	felt	bad	
I	would	rather	be	doing	
something	else	
1	 2	 3	 4	 5	 6	 7	 There	is	nothing	else	I	
would	rather	be	doing	
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